Creating a new leader in reproductive endocrinology
Reproductive endocrinology in the USA is a $9B+ industry, focused on reactively treating infertility.
We were tasked to establish Prelude as a viable business at launch, generate consumer awareness, support clinic acquisition, and demonstrate growth opportunities.
We used Prelude’s medical leaders as go-to resources for health and wellness media to reframe the nation’s cultural narrative from a focus on reactively treating infertility to nurturing fertility and the benefits of fertility preservation.
Krupp led with Prelude founder Martin Varsavsky’s personal story of overcoming infertility as his inspiration for creating Prelude.